ATE289811T1 - Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephriten - Google Patents
Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephritenInfo
- Publication number
- ATE289811T1 ATE289811T1 AT99929432T AT99929432T ATE289811T1 AT E289811 T1 ATE289811 T1 AT E289811T1 AT 99929432 T AT99929432 T AT 99929432T AT 99929432 T AT99929432 T AT 99929432T AT E289811 T1 ATE289811 T1 AT E289811T1
- Authority
- AT
- Austria
- Prior art keywords
- indomethacin
- angiotensin
- composition containing
- glomerulonephrites
- cronic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808976A FR2780890B3 (fr) | 1998-07-10 | 1998-07-10 | Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour le traitement des glomerulonephrites chroniques |
PCT/FR1999/001650 WO2000002556A1 (fr) | 1998-07-10 | 1999-07-08 | Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour la fabrication d'un medicament pour traiter les glomerulonephrites chroniques |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE289811T1 true ATE289811T1 (de) | 2005-03-15 |
Family
ID=9528595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99929432T ATE289811T1 (de) | 1998-07-10 | 1999-07-08 | Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephriten |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1115399B1 (de) |
AT (1) | ATE289811T1 (de) |
AU (1) | AU4625299A (de) |
DE (1) | DE69923982T2 (de) |
FR (1) | FR2780890B3 (de) |
WO (1) | WO2000002556A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1750862T3 (pl) | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
CA2632284A1 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 3-amino-2-arylpropyl azaindoles and uses thereof |
AU2006319231A1 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 3-amino-1-arylpropyl indoles and aza-substituted indoles |
-
1998
- 1998-07-10 FR FR9808976A patent/FR2780890B3/fr not_active Expired - Lifetime
-
1999
- 1999-07-08 AU AU46252/99A patent/AU4625299A/en not_active Abandoned
- 1999-07-08 EP EP99929432A patent/EP1115399B1/de not_active Expired - Lifetime
- 1999-07-08 WO PCT/FR1999/001650 patent/WO2000002556A1/fr active IP Right Grant
- 1999-07-08 AT AT99929432T patent/ATE289811T1/de not_active IP Right Cessation
- 1999-07-08 DE DE69923982T patent/DE69923982T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2000002556A1 (fr) | 2000-01-20 |
DE69923982T2 (de) | 2006-03-30 |
EP1115399A1 (de) | 2001-07-18 |
AU4625299A (en) | 2000-02-01 |
DE69923982D1 (de) | 2005-04-07 |
FR2780890A1 (fr) | 2000-01-14 |
EP1115399B1 (de) | 2005-03-02 |
FR2780890B3 (fr) | 2000-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69925024D1 (de) | Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten | |
DE602005026169D1 (de) | Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen | |
WO2004058717A8 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
BR0110028A (pt) | Uso de antagonistas-ngf para a prevenção ou tratamento de dor visceral crÈnica | |
WO2005107726A3 (en) | Method for the treatment of back pain | |
SG163564A1 (en) | Kinin antagonists for treating bladder dysfunction | |
BR0007595A (pt) | 4-(heterociclisulfonamido)-5-metóxi-6-(2-metoxifenó xi)-2-fenil-ou piridilpirimidinas como antagonistas de receptor de endotelina | |
DE60212146D1 (de) | Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv | |
ATE288747T1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
BRPI0908635B8 (pt) | composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica | |
ATE463514T1 (de) | ANTAGONISTEN DER INTERAKTION ZWISCHEN FAKTOR VIII UND LRP (ßLOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEINß) | |
DK1551803T3 (da) | Azabicycloderivater som muskarine receptorantagonister | |
CY1105257T1 (el) | Χρηση των ανταγωνιστων των υποδοχεων της αγγειοτενσινης ii στην θepαπεια του οξεος εμφραγματος του μυοκαρδιου | |
DE502004011551D1 (de) | 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen | |
ATE366572T1 (de) | 5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert | |
DE69711078T2 (de) | Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz | |
ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
ATE332688T1 (de) | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung | |
ATE367160T1 (de) | Piperazin-derivate zur verwendung als ccr-3 rezeptor antagonisten zur behandlung von asthma | |
DE69819742D1 (de) | Indolderivate als 5-ht1b und 5-ht1d agonisten | |
PT1000046E (pt) | Derivados de piperazina activos no trato urinario inferior | |
ATE289811T1 (de) | Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephriten | |
EA200601592A1 (ru) | Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора | |
DE60313898D1 (de) | Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten | |
MX2007004461A (es) | Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |